ticker,nameOfIssuer,cusip,value,shares,allocation_percent,filingDate,reportDate,accessionNumber
IONS,Ionis Pharmaceuticals Inc.,462222100,375400000.0,8516334,10.374911838122634,2018-05-08,2018-03-31,0000950123-18-004349
INCY,Incyte Corp.,45337C102,308181000.0,3698322,8.517183551370461,2018-05-08,2018-03-31,0000950123-18-004349
CELG,Celgene Corp,151020104,296561000.0,3324298,8.196042167356117,2018-05-08,2018-03-31,0000950123-18-004349
NBIX,Neurocrine Biosciences Inc.,64125C109,282190000.0,3402753,7.798871527969702,2018-05-08,2018-03-31,0000950123-18-004349
VRTX,Vertex Pharmaceuticals Inc.,92532F100,240468000.0,1475445,6.645802610254857,2018-05-08,2018-03-31,0000950123-18-004349
RDUSEUR,Radius Health Inc.,750469207,210386000.0,5853799,5.814427815597412,2018-05-08,2018-03-31,0000950123-18-004349
AGIO,Agios Pharmaceuticals Inc.,00847X104,207333000.0,2535253,5.7300522006752255,2018-05-08,2018-03-31,0000950123-18-004349
GILD,Gilead Sciences Inc.,375558103,201638000.0,2674596,5.572659758165614,2018-05-08,2018-03-31,0000950123-18-004349
ESPR,Esperion Therapeutics Inc.,29664W105,174530000.0,2412964,4.82347725921029,2018-05-08,2018-03-31,0000950123-18-004349
HALO,Halozyme Therapeutics Inc.,40637H109,166909000.0,8520137,4.612856046854583,2018-05-08,2018-03-31,0000950123-18-004349
SAGE,Sage Therapeutics Inc.,78667J108,161463000.0,1002439,4.462345205430992,2018-05-08,2018-03-31,0000950123-18-004349
ALXN,Alexion Pharmaceuticals Inc.,015351109,155423000.0,1394428,4.2954180144287,2018-05-08,2018-03-31,0000950123-18-004349
ALNY,Alnylam Pharmaceuticals Inc.,02043Q107,120450000.0,1011338,3.328870886792411,2018-05-08,2018-03-31,0000950123-18-004349
REGN,Regeneron Pharmaceuticals Inc.,75886F107,96421000.0,280000,2.6647825635152436,2018-05-08,2018-03-31,0000950123-18-004349
T8S,Tesaro Inc.,881569107,93124000.0,1629743,2.5736635322678,2018-05-08,2018-03-31,0000950123-18-004349
N/A,Myovant Sciences Ltd.,G637AM102,74613000.0,3507882,2.0620759109692166,2018-05-08,2018-03-31,0000950123-18-004349
MGNX,MacroGenics Inc.,556099109,65426000.0,2600412,1.808175231542385,2018-05-08,2018-03-31,0000950123-18-004349
AKCAEUR,"Akcea Therapeutics, Inc.",00972L107,61197000.0,2389571,1.6912985608886277,2018-05-08,2018-03-31,0000950123-18-004349
N/A,"AveXis, Inc.",05366U100,49778000.0,402800,1.375712204256975,2018-05-08,2018-03-31,0000950123-18-004349
ITCIEUR,Intra-Cellular Therapies Inc.,46116X101,46310000.0,2200000,1.2798672541914202,2018-05-08,2018-03-31,0000950123-18-004349
VYGR,Voyager Therapeutics Inc.,92915B106,37442000.0,1992641,1.0347827625012989,2018-05-08,2018-03-31,0000950123-18-004349
N/A,Wave Life Sciences Ltd.,Y95308105,35933000.0,896096,0.9930786017028785,2018-05-08,2018-03-31,0000950123-18-004349
ICPTUSD,Intercept Pharmaceuticals Inc.,45845P108,33573000.0,545719,0.9278553946225124,2018-05-08,2018-03-31,0000950123-18-004349
ARGX,Argenx SE,04016X101,31920000.0,396819,0.8821715127141034,2018-05-08,2018-03-31,0000950123-18-004349
ALDR1EUR,Alder Biopharmaceuticals Inc.,014339105,28778000.0,2266008,0.7953362090503281,2018-05-08,2018-03-31,0000950123-18-004349
N/A,Novavax Inc.,670002104,17493000.0,8330000,0.483453204007137,2018-05-08,2018-03-31,0000950123-18-004349
FPRX,Five Prime Therapeutics Inc.,33830X104,16793000.0,977500,0.46410733750024874,2018-05-08,2018-03-31,0000950123-18-004349
PRTA,Prothena Corp. PLC,G72800108,14684000.0,400000,0.4058210054102097,2018-05-08,2018-03-31,0000950123-18-004349
N/A,Cidara Therapeutics Inc.,171757107,9181000.0,2295272,0.2537348577139156,2018-05-08,2018-03-31,0000950123-18-004349
ACHNEUR,Achillion Pharmaceuticals Inc.,00448Q201,4746000.0,1279340,0.13116497491670223,2018-05-08,2018-03-31,0000950123-18-004349
